Redirecting innovation in U.S. health care : options to decrease spending and increase value / Steven Garber [and others].
Material type:
TextSeries: RAND Corporation research report series ; RR-308.Copyright date: ©2014Description: 1 online resource (xxvii, 105 pages) : illustrationsContent type: - text
- computer
- online resource
- 9780833085474
- 0833085476
- Medical care -- United States
- Medical care, Cost of -- United States
- Medical innovations
- Biomedical engineering
- Medical care, Cost of
- Cost effectiveness
- Medical care
- Medical policy
- Biomedical Technology
- Health Care Costs
- Cost-Benefit Analysis
- Delivery of Health Care
- Health Policy
- Inventions
- United States
- Soins médicaux -- Coût -- États-Unis
- Médecine -- Innovations
- Génie biomédical
- Soins médicaux -- Coût
- Coût-efficacité
- Prestation de soins
- Politique sanitaire
- biomedical engineering
- cost benefit analysis
- POLITICAL SCIENCE -- Public Policy -- Social Security
- POLITICAL SCIENCE -- Public Policy -- Social Services & Welfare
- MEDICAL -- Allied Health Services -- Medical Technology
- Medical care
- Medical care, Cost of
- Medical innovations
- United States
- 362.10973
- RA395.A3
- W 82
| Item type | Home library | Collection | Call number | Materials specified | Status | Date due | Barcode | |
|---|---|---|---|---|---|---|---|---|
Electronic-Books
|
OPJGU Sonepat- Campus | E-Books EBSCO | Available |
"RR-308"--Page 4 of cover.
Includes bibliographical references (pages 91-105).
New medical technologies are a leading driver of U.S. health care spending. This report identifies promising policy options to change which medical technologies are created, with two related policy goals: (1) Reduce total health care spending with the smallest possible loss of health benefits, and (2) ensure that new medical products that increase spending are accompanied by health benefits that are worth the spending increases.
Introduction -- The context for medical product innovation -- Methods -- Analysis -- Policy options to improve the U.S. medical product innovation system -- In conclusion -- Appendix A: Cost-effectiveness and value -- Appendix B: An economic model of innovation.
Print version record.
eBooks on EBSCOhost EBSCO eBook Subscription Academic Collection - Worldwide
There are no comments on this title.